Astellas Pharma, Inc. (ALPMY)
Astellas Pharma Market Cap : 29.00B for Feb. 19, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Nxera Pharma Co., Ltd. | 492.29M |
| PeptiDream Inc. | 1.198B |
| Stemcell Holdings, Inc. | 60.00M |
| Healios KK | 243.03M |
| AnGes, Inc. | 139.06M |
Market Cap Related Metrics
| PE Ratio | 13.51 |
| PS Ratio | 2.111 |
| Price to Book Value | 2.578 |
| Price to Free Cash Flow | 11.22 |
| Price | 16.19 |
| Earnings Yield | 7.40% |
| Operating PE Ratio | 10.75 |
| Normalized PE Ratio | 13.51 |